AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | +30.0% | 29,061 | -9.4% | 0.00% | 0.0% |
| Q4 2022 | $10 | -100.0% | 32,088 | -19.8% | 0.00% | -50.0% |
| Q3 2022 | $23,000 | -46.5% | 40,019 | -27.0% | 0.00% | -50.0% |
| Q2 2022 | $43,000 | -20.4% | 54,823 | +7.9% | 0.00% | 0.0% |
| Q1 2022 | $54,000 | +54.3% | 50,805 | +34.9% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -47.8% | 37,657 | +27.7% | 0.00% | -20.0% |
| Q1 2021 | $67,000 | -64.0% | 29,484 | -71.6% | 0.01% | -75.0% |
| Q4 2020 | $186,000 | +190.6% | 103,807 | +250.7% | 0.02% | +81.8% |
| Q3 2020 | $64,000 | -61.2% | 29,604 | -55.5% | 0.01% | -42.1% |
| Q2 2020 | $165,000 | – | 66,563 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,873 | $26,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 95,754 | $206,000 | 0.03% |
| Arkadios Wealth Advisors | 20,000 | $45,400,000 | 0.02% |
| Bayesian Capital Management, LP | 42,200 | $91,000 | 0.02% |
| SeaCrest Wealth Management, LLC | 50,515 | $109,000 | 0.02% |
| Virtu Financial LLC | 29,604 | $64,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $31,000 | 0.01% |
| WEDBUSH SECURITIES INC | 13,295 | $29,000 | 0.00% |
| Verition Fund Management LLC | 40,000 | $86,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11,600 | $25,000 | 0.00% |